You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 101 No. 8, August 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Choroidal Neovascularization in Fellow Eyes of Patients With Advanced Senile Macular Degeneration

Role of Laser Photocoagulation

Alex E. Jalkh, MD; Marcos P. Avila, MD; Clement L. Trempe, MD; J. Wallace McMeel, MD; Charles L. Schepens, MD

Arch Ophthalmol. 1983;101(8):1194-1197.


Abstract

• Choroidal neovascularization in fellow eyes of patients with advanced disciform macular scars usually has an unfavorable prognosis. Fifty-two such fellow eyes were treated, using the monochromatic green argon laser. The neovascular membranes were foveal in 24 eyes, juxtafoveal in ten eyes, and perifoveal in 18 eyes. Complete closure of the choroidal new vessels after treatment was seen in 46 eyes. Only one eye in the foveal group and five eyes in the juxtafoveal group had residual new vessels. After an average follow-up period of 16 months, improvement or stabilization of vision was seen in 36 eyes—18 eyes in the foveal group, four in the juxtafoveal group, and 14 in the perifoveal group. In view of the rewarding anatomical and functional results, photocoagulation, using the monochromatic green argon laser, should be considered in these high-risk eyes. Treatment of foveal neovascular membranes seems to be indicated if the visual acuity is 20/70 or worse.



Author Affiliations

From the Department of Retina Research, the Eye Research Institute of Retina Foundation and Retina Associates, Boston.


Footnotes

Accepted for publication Oct 8, 1982.

Reprint requests to the Library, the Eye Research Institute of Retina Foundation, 20 Staniford St, Boston, MA 02114 (Dr Jalkh).

Hal M. Freeman, MD, Felipe I. Tolentino, MD, Ronald C. Pruett, MD, John J. Weiter, MD, Martin A. Mainster, MD, and Sheldon M. Buzney, MD, allowed us to examine their patients.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Perifoveal Laser Treatment for Subfoveal Choroidal New Vessels in Age-Related Macular Degeneration: Results of a Randomized Clinical Trial
Coscas et al.
Arch Ophthalmol 1991;109:1258-1265.
ABSTRACT  

Subfoveal Choroidal Neovascular Membranes in Age-Related Macular Degeneration: Visual Prognosis in Eyes With Relatively Good Initial Visual Acuity
Guyer et al.
Arch Ophthalmol 1986;104:702-705.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.